Aidapak Recalls Repaglinide Tablets Due to Potential Label Mixup
Aidapak Services is recalling Repaglinide 1 mg tablets because they may have been mislabeled as Valsartan, Guaifenesin, or Magnesium Chloride.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported illnesses or injuries, which aligns with the rubric criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling Repaglinide 1 mg tablets (NDC 00169008281) due to a potential label mixup. The recalled Repaglinide tablets may have been mislabeled as Valsartan 40 mg, Guaifenesin 200 mg, or Magnesium Chloride 64 mg.
The affected Repaglinide tablets have the following pedigree and expiration codes: Pedigree AD52387_1 (EXP 5/17/2014), Pedigree W002855 (EXP 6/7/2014), and Pedigree W003924 (EXP 6/28/2014). The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Patients and healthcare providers should check their medication labels and contact their pharmacist or prescriber if they have the affected Repaglinide tablets. The FDA classifies this recall as Class II, indicating a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- REPAGLINIDE, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00169008281.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 500
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- REPAGLINIDE
- Tablet
- 1 mg has the following codes: Pedigree: AD52387_1
- EXP: 5/17/2014
- Pedigree: W002855
- EXP: 6/7/2014
- Pedigree: W003924
- EXP: 6/28/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02